Krystal Biotech, Inc. (KRYS)

Krystal Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	358.33	161.9	341.25	268.27	187.51
Short-Term Investments	173.85	217.27	96.85	2.99	6.17
Cash & Cash Equivalents	532.18	379.17	438.1	271.26	193.69
Cash Growth	40.35%	-13.45%	61.50%	40.05%	73.30%
Receivables	42.04	0	0	0	0
Inventory	6.99	0	0	0	0
Other Current Assets	6.71	4.61	4.17	3.8	2.2
Total Current Assets	587.91	383.78	442.27	275.06	195.88
Property, Plant & Equipment	168.23	169.73	119.58	34.17	11.18
Long-Term Investments	61.95	4.62	64.37	0	0.5
Other Long-Term Assets	0.26	0.32	0.07	1.61	1.46
Total Long-Term Assets	230.45	174.67	184.03	35.79	13.14
Total Assets	818.36	558.45	626.3	310.84	209.02
Accounts Payable	4.13	3.98	8.4	2.11	1.02
Current Debt	1.47	1.56	1.04	0.64	0.48
Other Current Liabilities	27.49	23.31	16.3	12.71	1.83
Total Current Liabilities	33.09	28.85	25.74	15.45	3.33
Long-Term Debt	6.62	7.37	6.98	3.31	2.78
Total Long-Term Liabilities	6.62	7.37	6.98	3.31	2.78
Total Liabilities	39.71	36.22	32.72	18.76	6.11
Total Debt	8.09	8.93	8.02	3.95	3.26
Debt Growth	-9.39%	11.33%	103.35%	20.97%	-
Retained Earnings	-269.83	-280.76	-140.78	-71.21	-39.05
Comprehensive Income	0.64	-0.73	-0.16	0.01	0.01
Shareholders' Equity	778.64	522.23	593.58	292.08	202.91
Net Cash / Debt	524.08	370.24	430.07	267.32	190.42
Net Cash / Debt Growth	41.55%	-13.91%	60.89%	40.38%	70.38%
Net Cash Per Share	18.88	14.52	19.38	14.23	11.98
Working Capital	554.82	354.93	416.53	259.61	192.55
Book Value Per Share	28.68	20.49	26.74	15.55	12.76

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).